Ensuring the integrity of microbiological test data is fundamental to drug product quality and patient safety. The FDA is particularly focused on the data integrity of microbial tests as these often use manual methods that could be open to error or fraud. At present, the soundness of traditional culture-based microbiological test data is largely determined by factors such as effective sampling, valid testing and the interpretation of results. A...

read more